Drosetux Syrup by Boiron 150 ml

Drosetux Syrup by Boiron

Drosetux is a homeopathic syrup developed by Boiron, designed to provide natural relief from coughs and related symptoms. Its gentle formula makes it an ideal solution for both children and adults, soothing irritation and promoting respiratory comfort.

Key Features:

• Natural Ingredients: Drosetux contains a blend of homeopathic remedies, including Drosera, Belladonna, Bryonia, and others. These ingredients work together to alleviate coughs, reduce throat irritation, and help ease breathing.

• Soothing Formula: The syrup's gentle formula is designed to coat the throat, providing immediate relief from irritation and discomfort caused by coughing. It's especially useful for dry, tickly coughs.

• Alcohol-Free and Sugar-Free: Drosetux is free from alcohol and sugar, making it suitable for children, diabetics, and those avoiding alcohol. Its natural sweeteners ensure it is palatable without added sugars.

• Trusted Brand: Boiron is a reputable homeopathic brand with decades of experience in natural health products. Drosetux upholds this tradition, offering a reliable solution for cough relief.

Directions for Use:

• Adults and children over 12 years: Take one tablespoonful (15 ml) 2-3 times daily, or as directed by a healthcare professional.
• Children aged 6-12 years: Take one teaspoonful (5 ml) 2-3 times daily, or as directed by a healthcare professional.

• Please read the following full disclosure before purchasing or using this product.

• Summary of Product Characteristics

  1. Name of the Medicinal Product:

  Drosetux Syrup by Boiron

  2. Qualitative and Quantitative Composition:

  • Drosera 3 DH: 0.3g
  • Belladonna 3 DH: 0.3g
  • Bryonia 3 DH: 0.3g
  • Ipeca 3 DH: 0.3g
  • Rumex crispus 3 DH: 0.3g
  • Spongia tosta 3 DH: 0.3g

  Each 150 ml bottle contains these ingredients.

  3. Pharmaceutical Form:

  Syrup, 150 ml bottle.

  4. Clinical Particulars:

  4.1 Therapeutic Indications:

  For the relief of coughs and related symptoms, including dry, tickly, or irritating coughs.

  4.2 Posology and Method of Administration:

  • Adults and children over 12 years: Take one tablespoonful (15 ml) 2-3 times daily, or as directed by a healthcare professional.
  • Children aged 6-12 years: Take one teaspoonful (5 ml) 2-3 times daily, or as directed by a healthcare professional.

  4.3 Contraindications:

  • Hypersensitivity to any of the ingredients.

  4.4 Special Warnings and Precautions for Use:

  • Consult a healthcare professional if symptoms persist or worsen.

  4.5 Interactions with Other Medicinal Products and Other Forms of Interaction:

  • No known interactions. Consult a healthcare professional before combining with other medications.

  4.6 Fertility, Pregnancy, and Lactation:

  • Consult a healthcare professional before use during pregnancy or while breastfeeding.

  4.7 Effects on Ability to Drive and Use Machines:

  • None known.

  4.8 Undesirable Effects:

  • None known. If adverse effects occur, discontinue use and consult a healthcare professional.

  4.9 Overdose:

  • Overdose is unlikely. In case of accidental ingestion of a large amount, seek medical advice.

  5. Pharmacological Properties:

  5.1 Pharmacodynamic Properties:

  • The homeopathic ingredients in Drosetux Syrup, including Drosera, Belladonna, and Bryonia, work together to alleviate coughs, reduce throat irritation, and help ease breathing.

  5.2 Pharmacokinetic Properties:

  • No specific pharmacokinetic data available for homeopathic remedies.

  6. Pharmaceutical Particulars:

  6.1 List of Excipients:

  • Water, natural sweeteners, and other excipients.

  6.2 Shelf Life:

  • Check the expiration date on the package.

  6.3 Special Precautions for Storage:

  • Store at room temperature, away from direct sunlight and moisture.

  6.4 Nature and Contents of the Container:

  • Available in a 150 ml bottle.

  6.5 Special Precautions for Disposal:

  • Dispose of unused syrup in accordance with local regulations.

  7. Marketing Authorization Holder:

  BOIRON

  8. Date of Revision:

  April 2024